BioSpace News Archive

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today reported financial results for the fourth quarter and full year ended December 31, 2019, including sales of TAVALISSE® (fostamatinib disodium hexahydrate) tablets, for the treatment of adults with chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous treatment.

Pfizer’s Upjohn Division CFO Sanjeev Narula selected for leadership role at combined company

zPREDICTA is the leading provider of tumor-specific 3D cell culture models for the in vitro testing of anti-cancer therapeutics.

UPnRIDE Robotics Ltd. announced that the U.S. Food and Drug Administration has cleared the UPnRIDE™ Robotic Standing Wheelchair for marketing and use in the U.S.

The spread of coronavirus also affects the event industry. Congresses and trade fairs are postponed or even canceled worldwide for fear of a pandemic.

PDS Biotechnology Corporation announced commencement of work under an Amended and Restated Material Transfer Agreement with Farmacore Biotechnology, experts in infectious diseases, to develop a novel tuberculosis immunotherapy based on Farmacore’s proprietary TB antigens and PDS Bio’s Versamune® platform technology.

The Company will award up to 20 academic scholarships to individuals diagnosed with Duchenne muscular dystrophy

Ibex Medical Analytics, the pioneer in artificial intelligence (AI)-powered cancer diagnostics, today announced CE-IVD Mark for the Galen™ Prostate solution for use in supporting pathologists in identification of suspected cancer on prostate core needle biopsies

RedHawk Nearing Completion of Steps Necessary to Seek Medicare and Medicaid Accreditation

AnPac Bio-Medical Science Co., Ltd. today announced that it has filed a provisional patent application on the use of AnPac Bio’s novel detection technology, methods and apparatus for coronavirus detection with the US Patent Trademark and Office